<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959074</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-URO-2012-04</org_study_id>
    <secondary_id>SNUH-URO-2012-04-DJ</secondary_id>
    <nct_id>NCT01959074</nct_id>
  </id_info>
  <brief_title>The Effect of Naftopidil for the Double-J Stent Discomfort</brief_title>
  <official_title>The Effect of Naftopidil for the Double-J Stent Discomfort: Multicenter, Randomized, Double-blind, Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dong-A ST Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is To confirm the efficacy of Naftopidil for reducing discomfort of ureteral stent
      after urinary stone surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Enrollment

             1. patients underwent Double-J ureteral stent indwelling after urological surgery
                during less than 15 days

             2. patients aged more than 20 years

        2. Randomization

             1. naftopidil 75 mg qd or placebo until Double-J stent removal

             2. Standard treatment with pain-killers on demand were also applied.(aceclofenac)

        3. Follow-up to the day of Double-J stent removal (Evaluation should be done at stent
           removal)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ureteral Stent Symptom Questionaire(USSQ) urinary symptom score</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
    <description>DJ stent removal should be done between study day 5 and 15.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>USSQ body pain score</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>USSQ general health score</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ work performance score</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ sexual matters score</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Prostate Symptom Score(IPSS), QoL score</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total analgesics use</measure>
    <time_frame>at the day of DJ stent removal, an expected average of 10 days (range: 5-15 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Disorder of Urinary Stent</condition>
  <arm_group>
    <arm_group_label>Naftopidil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This interventional group will receive analgesics and naftopidil 75mg po qd.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control groups with only analgesics</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control groups will receive only analgesics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naftopidil</intervention_name>
    <description>Naftopidil 75mg 1T qd hs</description>
    <arm_group_label>Naftopidil</arm_group_label>
    <other_name>Flivas(TM) in South Korea</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for Naftopidil</intervention_name>
    <description>Placebo 1T qd hs</description>
    <arm_group_label>Control groups with only analgesics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard treatment</intervention_name>
    <description>aceclofenac 100mg on demand</description>
    <arm_group_label>Naftopidil</arm_group_label>
    <arm_group_label>Control groups with only analgesics</arm_group_label>
    <other_name>Aceclofenac</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Patients to be undergone double-J stent indwelling

          -  &gt;= 20 years

          -  undergoing unilateral retrograde double J (DJ) stent placement planned for 5-15 days
             indwelling

        Exclusion Criteria:

          -  after percutaneous nephrolithotomy, open or laparoscopic ureterolithotomy presence of
             ureteral stone

          -  renal insufficiency (serum Cr &gt; 1.4)

          -  febrile urinary tract infection (fever &gt; 38.0Â°C, evidence of urinary infection )

          -  pregnancy or breast feeding

          -  solitary kidney

          -  hypersensitivity to Naftopidil

          -  current use of any alpha blocker, calcium channel blocker, corticosteroid moderate or
             sever cardiovascular or cerebrovascular disease

          -  hepatic dysfunction

          -  prior history of pelvic surgery or irradiation

          -  prior history of transurethral resection of bladder tumor or prostate surgery

          -  significant active medical illness which in the opinion of the investigator would
             preclude protocol treatment

          -  genetic disorder such ad galactose intolerance, lapp lactase deficiency,
             glucose-galactose malabsorption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Wook Jeong, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Kyunggi</state>
        <zip>463-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangwon National University Hospital</name>
      <address>
        <city>Chuncheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donguk University Ilsan Hospital</name>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Boramae Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chang Wook Jeong</investigator_full_name>
    <investigator_title>M.D, Ph.D.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Aceclofenac</mesh_term>
    <mesh_term>Naftopidil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

